MedTrace Logo

Research on Individualized Treatment for Alcoholism

NCT00523133 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 185

Last updated 2007-08-31

No results posted yet for this study

Summary

The purpose of this study was to compare the effects of two psychosocial treatments that differed in scope and intensity (Broad Spectrum Treatment and Motivational Enhancement Treatment) combined with 3 or 6 months of treatment with naltrexone on alcohol drinking behaviors in alcohol dependent patients.

Conditions

  • Alcohol Dependence

Interventions

DRUG

naltrexone

50 mg naltrexone daily for 3 months

DRUG

naltrexone

50 mg of naltrexone daily for 6 months

BEHAVIORAL

Broad Spectrum Treatment

8-14, one hour sessions over 6 months

BEHAVIORAL

Motivational Enhancement Treatment

4, 20 minute sessions over 3 months

Sponsors & Collaborators

  • VA Boston Healthcare System

    collaborator FED

  • Brown University

    collaborator OTHER

  • George Washington University

    collaborator OTHER

  • Indiana University School of Medicine

    lead OTHER

Principal Investigators

  • Dena Davidson, PhD · Indiana University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-09-30
Completion
2005-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00523133 on ClinicalTrials.gov